WEAV

CEO Share Sale: Weave Communications CEO Brett White sold 109,722 common shares at $11.258 each on March 17, as disclosed in a regulatory filing.

Company Updates: Weave has reported strong financial growth and strategic advances, with analysts raising the price target from $17 to $20.

Weave's Recognition: Weave has been awarded the TRANSACT Top 10 Payments ISVs Award for its innovative billing and payments solution tailored for small and medium-sized healthcare practices, highlighting its impact on improving patient payment experiences.

Patient Payment Preferences: A recent survey indicates that 65% of patients prefer healthcare providers offering flexible payment options, which Weave facilitates through its integrated payment solutions, enhancing revenue cycle management for healthcare practices.

Analyst Ratings: Mark Schappel from Loop Capital Markets maintains a Buy rating on Weave Communications with a price target of $18.00, while the analyst consensus is a Strong Buy with an average target of $18.75, indicating potential upside for investors.

Insider Activity: Recent corporate insider activity shows negative sentiment towards Weave Communications, with an increase in insiders selling shares, including CFO Alan Taylor who sold 789 shares earlier this month.

Analyst Rating and Price Target: Stifel Nicolaus analyst J. Parker Lane has maintained a Buy rating on Weave Communications, setting a price target of $20.00, while the stock closed at $16.89 with a consensus rating of Moderate Buy.

Insider Activity and Market Sentiment: Recent insider activity shows negative sentiment towards Weave Communications, with an increase in insiders selling shares, including CFO Alan Taylor who sold 789 shares earlier this month.

Insider Trading Activity: Blake G Modersitzki, a director at $WEAV, sold 2,688 shares for approximately $46,986, representing about 1.4% of his holdings, while insiders have conducted 113 sales and no purchases in the last six months.

Institutional Investor Movements: In the most recent quarter, 140 institutional investors increased their positions in $WEAV stock, while 54 reduced theirs.

Insider Trading Activity: Alan Taylor, CFO of $WEAV, sold 801 shares for approximately $13,841, marking a 0.3% reduction in his holdings, while insiders have conducted 110 sales and no purchases in the past six months.

Institutional Investor Movements: In the last quarter, 140 institutional investors increased their positions in $WEAV stock, while 54 reduced theirs, indicating varied confidence among institutional stakeholders.

New Integration Announcement: Weave has integrated with Practice Fusion to enhance communication workflows for healthcare businesses, offering features like automated data sync, VoIP phone system, two-way texting, and email marketing.

Benefits for Healthcare Practices: The integration aims to improve patient engagement, streamline operations, and boost profitability by providing tools that reduce administrative burdens and enhance the overall customer experience.

Insider Trading Activity: Blake G Modersitzki, a director at $WEAV, sold 20,711 shares for approximately $361,406, marking a sale of about 0.8% of his holdings; there have been 109 insider sales and no purchases in the past six months.

Institutional Investor Movements: In the latest quarter, 103 institutional investors increased their positions in $WEAV stock while 57 decreased theirs, indicating mixed sentiment among larger investors.

Equity Award Announcement: Weave Communications, Inc. has granted Jeff Tibbs, the new Corporate Controller & VP of Finance, an inducement equity award of restricted stock units for 30,000 shares, which will vest over three years contingent on his continued service.

Company Overview: Weave is a comprehensive customer experience and payments software platform designed for small and medium-sized healthcare businesses, recognized as a leader in various software categories related to patient management and engagement.

Equity Award Announcement: Weave Communications, Inc. has granted Jeff Tibbs, the new Corporate Controller & VP of Finance, an inducement equity award of restricted stock units for 30,000 shares, vesting over three years, as part of his employment agreement.

Company Overview: Weave is a customer experience and payments software platform tailored for small and medium-sized healthcare businesses, recognized for its leadership in various software categories related to patient management and engagement.

Weave Financial Results Announcement: Weave will release its financial results for Q4 and full year 2024 on February 20, 2025, followed by a conference call at 4:30 p.m. ET to discuss the results and provide a business update.

About Weave: Weave is a leading customer experience and payments software platform for small and medium-sized healthcare businesses, enhancing patient engagement and streamlining payment processes.

Weave's Recognition: Weave, a customer experience and payments software platform for healthcare businesses, won multiple APPEALIE SaaS awards for excellence in Analytics, Customer Service, ERP, and Finance, highlighting its commitment to customer satisfaction and innovative solutions.

Innovative Features: The platform recently launched a redesigned interface with AI tools that enhance patient communication, automate tasks, and provide actionable insights, further supporting healthcare practices in improving operations and profitability.

Integration Benefits: Weave has announced an integration with Prompt to streamline physical therapy practice management, enhancing patient communication, scheduling, and billing processes while reducing administrative burdens.

Improved Patient Engagement: The integration aims to boost patient engagement and satisfaction through advanced communication tools, automated reminders, and seamless payment options, ultimately leading to better operational efficiency and cash flow for practices.

Weave's Recognition: Weave, a customer experience and payments software platform for healthcare businesses, ranked first in 23 categories in the G2 2025 Winter Report and earned 45 badges, including Best Patient Relationship Management Software, reflecting its commitment to customer satisfaction.

Enhanced Features and Mission: The company recently introduced AI-powered Call Intelligence to improve healthcare experiences, emphasizing its mission to enhance relationships between providers and patients while also receiving accolades for workplace excellence and business performance.

Insider Trading Activity: Blake G Modersitzki, a director at $WEAV, sold 56,126 shares for approximately $926,640, representing about 1.9% of his holdings, while insiders have conducted 103 sales and no purchases in the past six months.

Institutional Investor Movements: In the latest quarter, 86 institutional investors increased their stakes in $WEAV, while 60 reduced theirs, indicating mixed sentiment among large shareholders.

Insider Trading Activity: Alan Taylor, CFO of $WEAV, sold 794 shares on January 13, 2025, representing about 0.3% of his holdings, leaving him with 282,722 shares; in the past six months, there have been 93 insider sales and no purchases of $WEAV stock.

Institutional Investor Movements: In the latest quarter, 85 institutional investors increased their positions in $WEAV while 59 reduced theirs, indicating mixed sentiment among larger stakeholders.

Generational Trends in Health Research: A survey by Weave highlights that Millennials actively research symptoms before appointments, while Gen Z uses online information cautiously. Baby Boomers tend to trust their doctors more than online advice.

Impact of Online Research on Patient-Provider Relationships: The study indicates that patients increasingly expect healthcare providers to engage with their online findings, with a significant portion of Gen Z feeling upset if their concerns are dismissed, emphasizing the need for open communication and trust-building.

Insider Trading Activity: Blake G Modersitzki, a director at $WEAV, sold 5,947 shares of the company, representing about 2.8% of his holdings, leaving him with 207,979 shares. In the past six months, all 80 insider trades were sales, with no purchases reported.

Institutional Investment Trends: Recent data shows that 83 institutional investors increased their positions in $WEAV stock, while 78 reduced theirs in the last quarter, indicating mixed sentiment among larger investors.

Weave's Recognition: Weave, a customer experience and payments software platform for healthcare businesses, has been awarded the 2024 Top Workplaces Culture Excellence in five categories based on employee feedback, highlighting its commitment to a people-first workplace culture.

Additional Accolades: This recognition follows several other awards for Weave, including rankings among the best places to work in Utah and being featured on Inc.'s Annual List of Best Workplaces for 2024, showcasing its growth and positive workplace environment.

Weave's Recognition: Weave, a customer experience and payments software platform for healthcare businesses, has been awarded the 2024 Inc. Power Partner Award for its significant role in supporting entrepreneurs and driving business growth.

Impact on Healthcare Providers: The platform enhances patient engagement and streamlines payment processes, allowing healthcare providers to focus more on patient care while improving operational efficiency and profitability.